Skip to main content

Neurology and Therapy

Ausgabe 3/2022

Inhalt (32 Artikel)

Open Access COVID-19 Review

A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies

Jeri Burtchell, Daisy Clemmons, Joann Clemmons, Tim Sabutis, Adeline Rosenberg, Jennifer Graves, Michael L. Sweeney, John Kramer, Marina Ziehn, Brandon Brown, Jamie L. Weiss, Ahmed Z. Obeidat

Open Access Review

A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis

Nicolas Collongues, Guillaume Becker, Valérie Jolivel, Estelle Ayme-Dietrich, Jérôme de Seze, Fabien Binamé, Christine Patte-Mensah, Laurent Monassier, Ayikoé Guy Mensah-Nyagan

Open Access Review

Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes

Tanuja Chitnis, Jo Vandercappellen, Miriam King, Giampaolo Brichetto

Open Access Original Research

The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment

Andreas Meisel, Jörn P. Sieb, Gwendal Le Masson, Ville Postila, Sabrina Sacconi

Open Access Original Research

Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool

Amir Abbas Tahami Monfared, William R. Lenderking, Yulia Savva, Mary Kate Ladd, Quanwu Zhang, James Brewer, Oscar Lopez, Bradley Hyman, Thomas Grabowski, Mary Sano, Helena Chui, Marilyn Albert, John Morris, Jeffrey Kaye, Thomas Wisniewski, Scott Small, John Trojanowski, Charles DeCarli, Andrew Saykin, David Bennett, Roger Rosenberg, Neil Kowall, Robert Vassar, Frank LaFerla, Ronald Petersen, Eric Reiman, Bruce Miller, Allan Levey, Linda Eldik, Sanjay Asthana, Russell Swerdlow, Todd Golde, Stephen Strittmatter, Victor Henderson, Suzanne Craft, Henry Paulson, Sudha Seshadri, Erik Roberson, Marwan Sabbagh, Gary Rosenberg, Angela Jefferson, Heather Whitson, James Leveren

Open Access Original Research

Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study

José E. Meca-Lallana, Rocío Gómez-Ballesteros, Francisco Pérez-Miralles, Lucía Forero, María Sepúlveda, Carmen Calles, María L. Martínez-Ginés, Inés González-Suárez, Sabas Boyero, Lucía Romero-Pinel, Ángel P. Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Daniel Prefasi, Jorge Maurino

Open Access Original Research

Construction of an Assisted Model Based on Natural Language Processing for Automatic Early Diagnosis of Autoimmune Encephalitis

Yunsong Zhao, Bin Ren, Wenjin Yu, Haijun Zhang, Di Zhao, Junchao Lv, Zhen Xie, Kun Jiang, Lei Shang, Han Yao, Yongyong Xu, Gang Zhao

Open Access COVID-19 Original Research

COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional Study

Venja Musche, Alexander Bäuerle, Lisa Jahre, Adam Schweda, Hannah Dinse, Sheila Moradian, Benjamin Weismüller, Madeleine Fink, Anna Wolters, Michael Fleischer, Christoph Kleinschnitz, Martin Teufel, Eva-Maria Skoda, Mark Stettner

Open Access Original Research

The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices

Ilse S. Peterson, Allison J. Mazzella, Lisa T. Belter, Mary A. Curry, Rosángel E. Cruz, Jill Jarecki

Open Access Original Research

Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain

Alberto Villarejo-Galende, Elena García-Arcelay, Gerard Piñol-Ripoll, Antonio del Olmo-Rodríguez, Félix Viñuela, Mercè Boada, Emilio Franco-Macías, Almudena Ibañez de la Peña, Mario Riverol, Albert Puig-Pijoan, Pedro Abizanda-Soler, Rafael Arroyo, Miquel Baquero-Toledo, Inmaculada Feria-Vilar, Mircea Balasa, Ángel Berbel, Eloy Rodríguez-Rodríguez, Alba Vieira-Campos, Guillermo García-Ribas, Silvia Rodrigo-Herrero, Albert Lleó, Jorge Maurino

Open Access Original Research

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

Maria Petracca, Serena Ruggieri, Elena Barbuti, Antonio Ianniello, Roberta Fantozzi, Giorgia Teresa Maniscalco, Vincenzo Andreone, Doriana Landi, Girolama Alessandra Marfia, Maria Di Gregorio, Rosa Iodice, Leonardo Sinisi, Elisabetta Maida, Rosanna Missione, Cinzia Coppola, Simona Bonavita, Giovanna Borriello, Diego Centonze, Giacomo Lus, Carlo Pozzilli, Elisabetta Signoriello

Open Access Original Research

Therapeutic Decision-Making Under Uncertainty in the Management of Spinal Muscular Atrophy: Results From DECISIONS-SMA Study

Gustavo Saposnik, Ana Camacho, Paola Díaz-Abós, María Brañas-Pampillón, Victoria Sánchez-Menéndez, Rosana Cabello-Moruno, María Terzaghi, Jorge Maurino, Ignacio Málaga

Open Access Original Research

Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study

Xiaoqin Yang, Hyun Kyoo Yoo, Suvina Amin, Wendy Y. Cheng, Sanjana Sundaresan, Lujia Zhang, Mei S. Duh

Open Access Original Research

Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety

Simona Lattanzi, Eugen Trinka, Claudia Altamura, Cinzia Del Giovane, Mauro Silvestrini, Francesco Brigo, Fabrizio Vernieri

Open Access Original Research

Treatment Status and Healthcare Cost Trends for Patients with Multiple Sclerosis in Japan: A Claims Database Analysis

Izumi Kawachi, Hiromichi Otaka, Kosuke Iwasaki, Tomomi Takeshima, Kengo Ueda

Open Access Original Research

Efficacy and Safety of Lasmiditan as a Novel Acute Treatment in Chinese Patients with Migraine: A Subpopulation Analysis of the Randomized Controlled Phase 3 CENTURION Trial

Tingmin Yu, Li He, Xiaosu Yang, Jiying Zhou, Guogang Luo, Hebo Wang, Hongru Zhao, Quan Hu, Fei Ji, Shengyuan Yu

Open Access Original Research

The Potential Economic Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling

Amir Abbas Tahami Monfared, Ali Tafazzoli, Ameya Chavan, Weicheng Ye, Quanwu Zhang

Open Access Original Research

Long-Term Clinical Experience with Directional Deep Brain Stimulation Programming: A Retrospective Review

Jessica A. Karl, Jessica Joyce, Bichun Ouyang, Leo Verhagen Metman

Open Access Original Research

Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment

Thomas Morel, Sophie Cleanthous, John Andrejack, Roger A. Barker, Geraldine Blavat, William Brooks, Paul Burns, Stefan Cano, Casey Gallagher, Lesley Gosden, Carroll Siu, Ashley F. Slagle, Kate Trenam, Babak Boroojerdi, Natasha Ratcliffe, Karlin Schroeder

Open Access Original Research

Clinical Staging of Alzheimer’s Disease: Concordance of Subjective and Objective Assessments in the Veteran’s Affairs Healthcare System

Peter Morin, Mingfei Li, Ying Wang, Byron J. Aguilar, Dan Berlowitz, Amir Abbas Tahami Monfared, Michael Irizarry, Quanwu Zhang, Weiming Xia

Open Access Original Research

Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study

Valérie Bourdès, Peter Dogterom, André Aleman, Pierre Parmantier, Damien Colas, Sighild Lemarchant, Sébastien Marie, Thomas Chou, Khalid Abd-Elaziz, Yann Godfrin

Open Access Original Research

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

Efthymios Dardiotis, Georgia Perpati, Mariann Borsos, Ioannis Nikolaidis, Dimitrios Tzanetakos, Georgia Deretzi, Evangelos Koutlas, Constantinos Kilidireas, Dimos Dimitrios Mitsikostas, Georgios Hadjigeorgiou, Nikolaos Grigoriadis, Sotirios Papagiannopoulos, Anastasios Orologas, Panagiotis Aggelidakis, Antonios Antonios, Nicolaos Fakas, Alexandros Papadimitriou, Ioannis Iliopoulos, Vasiliki Kostadima, Klimentini Karageorgiou, Sotirios Lamprakopoulos, Dimitrios Nikiforidis, Konstantinos Voumvourakis, Afroditi Kaponi, Maria Maltezou, Tereza Pasqua Acquaviva, Elli Kerezoudi, Georgios Balamoutsos, Antonios Kerasnoudis, Georgia Deretzi, Panayiotis Mitsias, Triantafyllos Doskas, Thomas Maris, Christos Baltogiannis, Elisavet Chroni

Open Access Study Protocol

Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial

Joaquim J. Ferreira, Werner Poewe, Olivier Rascol, Fabrizio Stocchi, Angelo Antonini, Joana Moreira, Ana Pereira, José-Francisco Rocha, Patrício Soares-da-Silva

Open Access Letter

A Response to: Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”

Dean M. Wingerchuk, Ina Zhang, Adrian Kielhorn, Minying Royston, Michael Levy, Kazuo Fujihara, Ichiro Nakashima, Imran Tanvir, Friedemann Paul, Sean J. Pittock

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.